Skip to main content

Table 2 Survival data from randomized controlled trials investigating TACE in HCC patients

From: Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?

Study Patients (n) Therapy 1-year overall survival (%) 2-year overall survival (%) 3-year overall survival (%)
Lin et al. (1988)[119] 63 21 TAE 42 25 NR
21 TAE + 5-FU iv 20 20 NR
21 5-FU iv 13 13 NR
Pelletier et al. (1990)[120] 42 21 TACE 24 NR NR
21 Conservative 31 NR NR
Groupe d’Etude (1995)[121] 96 50 TACE 62 38 NR
46 Conservative 43 26 NR
Pelletier et al. (1998)[122] 73 37 TACE 51 24 NR
36 Tamoxifen 55 26 NR
Lo et al. (2002)[117] 79 40 TACE 57 31 26
39 Conservative 32 11 3
Llovet et al. (2002)[116] 112 40 TACE 82 63 29
37 TAE 75 50 29
35 Conservative 63 27 17
  1. TACE = transcatheter arterial chemoembolization, TAE = transcatheter arterial (bland) embolization, NR = not reported